Paul Tudor Jones Cv Rx, Inc. Transaction History
Tudor Investment Corp Et Al
- $200 Billion
- Q3 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 126,060 shares of CVRX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,060
Previous 153,596
17.93%
Holding current value
$1.15 Million
Previous $903,000
9.08%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
14.3MCall Options Held
59.5KPut Options Held
30.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$37.3 Million7.51% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$18.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$9.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.97 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL696KShares$6.34 Million0.01% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $187M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...